BX Lab
Request a quote

Modified Nucleosides

5-Carbamoylhydroxymethyluridine

Quick view. Modified uridine bearing an alpha-hydroxyacetamide substituent at the 5-position of the uracil base. CAS 2450329-74-3. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.

Structure of 5-Carbamoylhydroxymethyluridine BX-MN-0414
Chemical structure
Catalog numberBX-MN-0414
CAS number2450329-74-3
Purity≥98%
Pack sizeCustom packaging by inquiry

Product profile

Material identity

5-Carbamoylhydroxymethyluridine is classified as modified nucleosides (Formula C11H15N3O8; molecular weight 317.25 g/mol).

Typical application

5-Carbamoylhydroxymethyluridine is associated with uridine-containing substrates for U-position incorporation in RNA or modified RNA studies.

Handling focus

For 5-Carbamoylhydroxymethyluridine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.

Names and search terms

Confirmed or normalized name variants

Useful catalog search terms

Physicochemical data

Systematic name2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]-2-hydroxyacetamide
Chemical formNeutral uridine with a base-5 alpha-hydroxyacetamide substituent
Stereochemical scopeRibose stereochemistry encoded; side-chain hydroxy center unspecified (R/S)
InChIKeyCMLZLJSTEBFOFC-XXWJQXOGSA-N

Release documentation

Lot-specific CoA

The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.

Analytical package

Additional HPLC, MS or NMR documentation can be agreed during technical review where available.

Related products

Frequently asked questions

Can the package size for 5-Carbamoylhydroxymethyluridine be customized?

Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.

What information should be included in a quote request?

Quote catalog number BX-MN-0414 and CAS 2450329-74-3, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.

Product-family literature

These publications provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.

Request a quote

Technology platforms

Catalog-derived platform membership for navigating related chemistry and verifiable product sets.